386 related articles for article (PubMed ID: 32784716)
1. Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications.
Minoli M; Kiener M; Thalmann GN; Kruithof-de Julio M; Seiler R
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784716
[TBL] [Abstract][Full Text] [Related]
2. Bladder Tumor Subtype Commitment Occurs in Carcinoma
Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
[TBL] [Abstract][Full Text] [Related]
3. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
[TBL] [Abstract][Full Text] [Related]
4. Contemporary Molecular Classification of Urinary Bladder Cancer.
Goutas D; Tzortzis A; Gakiopoulou H; Vlachodimitropoulos D; Giannopoulou I; Lazaris AC
In Vivo; 2021; 35(1):75-80. PubMed ID: 33402452
[TBL] [Abstract][Full Text] [Related]
5. Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities.
Trilla-Fuertes L; Gámez-Pozo A; Prado-Vázquez G; Zapater-Moros A; Díaz-Almirón M; Arevalillo JM; Ferrer-Gómez M; Navarro H; Maín P; Espinosa E; Pinto Á; Vara JÁF
BMC Cancer; 2019 Jun; 19(1):636. PubMed ID: 31253132
[TBL] [Abstract][Full Text] [Related]
6. The evolution of bladder cancer genomics: What have we learned and how can we use it?
Audenet F; Attalla K; Sfakianos JP
Urol Oncol; 2018 Jul; 36(7):313-320. PubMed ID: 29573965
[TBL] [Abstract][Full Text] [Related]
7. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer.
Benítez R; Yu K; Sirota M; Malats N; Pineda S
Front Immunol; 2023; 14():986598. PubMed ID: 36817478
[TBL] [Abstract][Full Text] [Related]
9. Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases.
Sjödahl G; Eriksson P; Lövgren K; Marzouka NA; Bernardo C; Nordentoft I; Dyrskjøt L; Liedberg F; Höglund M
Mod Pathol; 2018 Dec; 31(12):1869-1881. PubMed ID: 29967424
[TBL] [Abstract][Full Text] [Related]
10. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
Kamoun A; de Reyniès A; Allory Y; Sjödahl G; Robertson AG; Seiler R; Hoadley KA; Groeneveld CS; Al-Ahmadie H; Choi W; Castro MAA; Fontugne J; Eriksson P; Mo Q; Kardos J; Zlotta A; Hartmann A; Dinney CP; Bellmunt J; Powles T; Malats N; Chan KS; Kim WY; McConkey DJ; Black PC; Dyrskjøt L; Höglund M; Lerner SP; Real FX; Radvanyi F;
Eur Urol; 2020 Apr; 77(4):420-433. PubMed ID: 31563503
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of the luminal class of urothelial tumors.
Bernardo C; Eriksson P; Marzouka NA; Liedberg F; Sjödahl G; Höglund M
J Pathol; 2019 Nov; 249(3):308-318. PubMed ID: 31232464
[TBL] [Abstract][Full Text] [Related]
12. Bladder cancer genomics.
Siracusano S; Rizzetto R; Porcaro AB
Urologia; 2020 May; 87(2):49-56. PubMed ID: 31942831
[TBL] [Abstract][Full Text] [Related]
13. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
Seiler R; Ashab HAD; Erho N; van Rhijn BWG; Winters B; Douglas J; Van Kessel KE; Fransen van de Putte EE; Sommerlad M; Wang NQ; Choeurng V; Gibb EA; Palmer-Aronsten B; Lam LL; Buerki C; Davicioni E; Sjödahl G; Kardos J; Hoadley KA; Lerner SP; McConkey DJ; Choi W; Kim WY; Kiss B; Thalmann GN; Todenhöfer T; Crabb SJ; North S; Zwarthoff EC; Boormans JL; Wright J; Dall'Era M; van der Heijden MS; Black PC
Eur Urol; 2017 Oct; 72(4):544-554. PubMed ID: 28390739
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival.
Helal DS; Darwish SA; Awad RA; Ali DA; El-Guindy DM
Diagn Pathol; 2023 Feb; 18(1):11. PubMed ID: 36737799
[TBL] [Abstract][Full Text] [Related]
15. Molecular Subtypes of Bladder Cancer.
McConkey DJ; Choi W
Curr Oncol Rep; 2018 Aug; 20(10):77. PubMed ID: 30128829
[TBL] [Abstract][Full Text] [Related]
16. The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.
Chen Z; Ding W; Xu K; Tan J; Sun C; Gou Y; Tong S; Xia G; Fang Z; Ding Q
PLoS One; 2012; 7(10):e47199. PubMed ID: 23082147
[TBL] [Abstract][Full Text] [Related]
17. Genomic Subtyping in Bladder Cancer.
Jalanko T; de Jong JJ; Gibb EA; Seiler R; Black PC
Curr Urol Rep; 2020 Mar; 21(2):9. PubMed ID: 32166460
[TBL] [Abstract][Full Text] [Related]
18. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer.
McConkey DJ; Choi W; Ochoa A; Siefker-Radtke A; Czerniak B; Dinney CP
Hematol Oncol Clin North Am; 2015 Apr; 29(2):377-94, x-xi. PubMed ID: 25836941
[TBL] [Abstract][Full Text] [Related]
20. Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy.
Schnitzler T; Ortiz-Brüchle N; Schneider U; Lurje I; Guricova K; Buchner A; Schulz GB; Heidenreich A; Gaisa NT; Knüchel R; Garczyk S
Cell Oncol (Dordr); 2020 Oct; 43(5):807-819. PubMed ID: 32445084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
